中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 1
Jan.  2014
Turn off MathJax
Article Contents

ROC analysis of prognostic factors in Chinese patients with primary biliary cirrhosis

DOI: 10.3969/j.issn.1001-5256.2014.01.017
Research funding:

 

  • Received Date: 2013-05-08
  • Published Date: 2014-01-20
  • Objective To investigate and assess prognostic factors for survival in patients with primary biliary cirrhosis ( PBC) by receiver operating characteristics ( ROC) curves and Kaplan- Meier methods. Methods A total of 155 patients were identified and followed. Terminal events were death and / or liver transplantation. The optimal thresholds for continuous variables were established by ROC curves and cumulative proportions of patients developing an event were estimated using the Kaplan- Meier method. Results During a median follow- up period of 50 months ( range: 6- 316) , 36 patients died or underwent liver transplantation. Age 55 years or older, Total Bilirubin ( TBil) > 1. 8mg / dl, serum IgG > 17. 2 g / L, and Mayo risk score ( MRS) > 6. 11 were associated with mortality. With four markers in series test, their sensitivity was 99. 18%, specificity was 5. 56%, the total coincidence rate was 79. 23%; With four markers in parallel test, their sensitivity was 100%, specificity was 24. 51%, the total coincidence rate was 40. 77%. Age 55 years or older ( P = 0. 001) , TBil > 1. 8mg / dl ( P = 0. 005) , serum IgG > 17. 2 g / L ( P = 0. 001) , and MRS > 6. 11 ( P < 0. 000 1) were significantly associated with mortality. Conclusion Age 55 years or older, TBil > 1. 8mg / dL, serum IgG > 17. 2 g / L, and MRS > 6. 11 might predict survival for PBC patients with liver cirrhosis.

     

  • loading
  • [1]European Association for the Study of the Liver.EASL clinical practice guidelines:management of cholestatic liver diseases[J].J Hepatol, 2009, 51 (2) :237-267.
    [2]JIN HH, DING XH.ROC curve analysis of blood platelet and hyaluronic acid levels for diagnosing cirrhosis[J].J Clin Hepatol, 2012, 28 (6) :456-458. (in Chinese) 金宏慧, 丁晓红.受试者工作特征曲线分析血小板计数与透明质酸对肝硬化的诊断价值[J].临床肝胆病杂志, 2012, 28 (6) :456-458.
    [3]WU XQ, WAN H.Causes of failure and impact analysis of prognostic risk factors[J].J Clin Hepatol, 2013, 29 (4) :294-296. (in Chinese) 吴晓庆, 万红.肝衰竭预后的危险因素分析[J].临床肝胆病杂志, 2013, 29 (4) :294-296.
    [4]DICKSON ER, GRAMBSCH PM, FLEMING TR, et al.Prognosis in primary biliary cirrhosis:model for decision making[J].Hepatology, 1989, 10 (1) :1-7.
    [5] LINDOR KD, GERSHWIN ME, POUPON R, et al.Primary biliary cirrhosis[J].Hepatology, 2009, 50 (1) :291-308.
    [6]WONG GL, HUI AY, WONG VW, et al.A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients[J].Am J Gastroenterol, 2005, 100 (10) :2205-2211.
    [7]SU CW, HUNG HH, HUO TI, et al.Natural history and prognostic factors of primary biliary cirrhosis in Taiwan:a follow-up study up to 18 years[J].Liver Int, 2008, 28 (9) :1305-1313.
    [8]WONG RK, LIM SG, WEE A, et al.Primary biliary cirrhosisin Singapore:evaluation of demography, prognostic factors and natural course in a multi-ethnic population[J].J Gastroenterol Hepatol, 2008, 23 (4) :599-605.
    [9]PRINCE M, CHETWYND A, NEWMAN W, et al.Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis:follow-up for up to 28 years[J].Gastroenterology, 2002, 123 (4) :1044-1051.
    [10]PARS A, CABALLERíA L, RODS J.Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid[J].Gastroenterology, 2006, 130 (3) :715-720.
    [11]PETERS MG, di BISCEGLIE AM, KOWDLEY KV, et al.Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States[J].Hepatology, 2007, 46 (3) :769-775.
    [12]GERSHWIN ME, VIERLING JM, MANNS MP.Liver Immunology:principles and practice[M].NY:Humana Press, 2007:235-247.
    [13]KLION FM, FABRY TL, PALMER M, et al.Prediction of survival of patients with primary biliary cirrhosis.Examination of the Mayo Clinic model on a group of patients with known endpoint[J].Gastroenterology, 1992, 102 (1) :310-313.
    [14]KIM WR, WIESNER RH, THERNEAU TM, et al.Optimal timing of liver transplantation for primary biliary cirrhosis[J].Hepatology, 1998, 28 (1) :33-38.
    [15]VELZQUEZ RF, RODRíGUEZ M, NAVASCUS CA, et al.Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis[J].Hepatology, 2003, 37 (3) :520-527.
    [16]ZHAO DT, LIAO HY, LIU YM, et al.Prognostic factors and survival analysis of antimitochondrial antibody-positive primary biliary cirrhosis in Chinese patients[J].Dig Dis Sci, 2011, 56 (9) :2750-2757.
    [17]LIU YM, LIAO HY, YAN HP.Diagnosis of autoimmune liver diseases[J].Beijing Med J, 2012, 34 (12) :1084-1086. (in Chinese) 刘燕敏, 廖慧钰, 闫惠平.自身免疫性肝病诊断思路[J].北京医学, 2012, 34 (12) :1084-1086.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2936) PDF downloads(628) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return